zencogen

Zencogen is a preclinical stage biotech company developing breakthrough antibody based therapies to improve patient outcomes in oncologic diseases. Zencogen focuses on tumor specific novel targets for treating late stage cancers, with a pipeline of humanized and highly specific antibodies deployed through RDC and ADC. Zencogen is headquartered in Singapore, with RND based in Shanghai.

Address

Shanghai
China
Loading